Dr. David Hoogstra
Claim this profileHelen DeVos Children's Hospital
Studies Neuroblastoma
Studies Tumors
6 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials David Hoogstra is currently running
DFMO + Etoposide
for Neuroblastoma
This trial uses two drugs, DFMO and etoposide, to treat children whose neuroblastoma has come back or didn't respond to initial treatments. DFMO stops cancer cells from growing, and etoposide helps kill them. The study includes patients who are recovering after additional therapy, those who have had the disease return but are currently without symptoms, and those with active disease. DFMO has been evaluated as a follow-up treatment for severe neuroblastoma in previous studies.
Recruiting1 award Phase 2
GD2-SADA:177Lu-DOTA Complex
for Small Cell Lung Cancer
This trial tests a new treatment for certain cancers using a two-part method. The first part finds and attaches to cancer cells, and the second part delivers radiation to kill them. It aims to see if this treatment is safe and can be tolerated by patients with Small Cell Lung Cancer, Sarcoma, and Malignant Melanoma.
Recruiting1 award Phase 19 criteria
More about David Hoogstra
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments David Hoogstra has experience with
- Abemaciclib
- Temozolomide
- Difluoromethylornithine (DFMO)
- DFMO
- Ceritinib
- Dasatinib
Breakdown of trials David Hoogstra has run
Neuroblastoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hoogstra specialize in?
David Hoogstra focuses on Neuroblastoma and Tumors. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are undergoing treatment.
Is David Hoogstra currently recruiting for clinical trials?
Yes, David Hoogstra is currently recruiting for 4 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that David Hoogstra has studied deeply?
Yes, David Hoogstra has studied treatments such as Abemaciclib, Temozolomide, Difluoromethylornithine (DFMO).
What is the best way to schedule an appointment with David Hoogstra?
Apply for one of the trials that David Hoogstra is conducting.
What is the office address of David Hoogstra?
The office of David Hoogstra is located at: Helen DeVos Children's Hospital, Grand Rapids, Michigan 49503 United States. This is the address for their practice at the Helen DeVos Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.